                         SEQUENCE LISTING

<110>  Emergex Vaccines Holding Limited
       Rademacher, Thomas
       Huang, Xiaofang
 
<120>  Peptides

<130>  8259434

<150>  US63/196121
<151>  2021-06-02

<160>  39    

<170>  PatentIn version 3.5

<210>  1
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  1

Ala Met Leu Lys Cys Val Ala Phe Cys Asp Glu 
1               5                   10      


<210>  2
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  2

Ala Asn Gly Cys Ser Thr Ile Ala Gln Ala Val 
1               5                   10      


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  3

Ala Gln Gly Val Phe Gly Val Asn Met 
1               5                   


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  4

Ala Arg Leu Glu Pro Cys Asn Gly Thr Asp Ile Asp 
1               5                   10          


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  5

Ala Val Thr Thr Gly Asp Val Lys Ile Met 
1               5                   10  


<210>  6
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  6

Asp Ile Val Val Val Asp Glu Val Ser Met Cys Thr Asn Tyr Asp 
1               5                   10                  15  


<210>  7
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  7

Asp Ser Leu Cys Ala Lys Ala Val Thr Ala Tyr 
1               5                   10      


<210>  8
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  8

Glu Asp Phe Leu Asn Met Asp Ile Gly Val Phe Ile Gln 
1               5                   10              


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  9

Glu Val Asn Ala Asp Ile Val Val Val Asp Glu Val Ser Met Cys 
1               5                   10                  15  


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  10

Phe Val Gly Ala Asp Gly Glu Leu Pro Val 
1               5                   10  


<210>  11
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  11

Phe Val Lys Ser Ile Cys Asn Ser Ala Val Ala Val 
1               5                   10          


<210>  12
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  12

Phe Tyr Cys Thr Asn Asn Thr Leu Val Ser Gly Asp Ala His Ile 
1               5                   10                  15  


<210>  13
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  13

Gly Ala Lys Val Val Asn Ala Asn Val Leu Thr Lys 
1               5                   10          


<210>  14
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  14

Gly Tyr Ile Ala Asp Ile Ser Ala Phe 
1               5                   


<210>  15
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  15

Ile Ala Cys Ser Lys Ser Ala Arg Leu Lys Arg Phe Pro Val Asn 
1               5                   10                  15  


<210>  16
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  16

Ile Ala Asp Phe Leu Ala Gly Ser Ser Asp Val 
1               5                   10      


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  17

Ile Phe Ala Gln Thr Ser Asp Thr Ala 
1               5                   


<210>  18
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  18

Ile Val Gln Met Ile Ala Asp Phe Leu Ala 
1               5                   10  


<210>  19
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  19

Lys Phe Leu Asn Ala Phe Asp Val Phe Val Thr Ala Ile Gln 
1               5                   10                  


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  20

Leu Ile Ala Gly Lys Leu Leu Pro Pro Val 
1               5                   10  


<210>  21
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  21

Leu Asn Cys Ala Leu Gly Ala Phe Ala Ile Phe Cys Cys 
1               5                   10              


<210>  22
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  22

Met His Gly Val Thr Leu Lys Ile 
1               5               


<210>  23
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  23

Met Lys Val Lys Ala Thr Lys Gly Glu Gly Asp Gly Gly Ile 
1               5                   10                  


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  24

Asn Ala Met Leu Lys Cys Val Ala Phe 
1               5                   


<210>  25
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  25

Asn Glu Ala Asp Tyr Arg Cys Ala Cys Tyr Ala 
1               5                   10      


<210>  26
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  26

Pro Asn Leu Asn Leu Gly Ile Leu Gln Val Thr 
1               5                   10      


<210>  27
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  27

Pro Ser Leu Val Met Pro Pro Ser Pro Ser Pro Leu Val 
1               5                   10              


<210>  28
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  28

Gln Ala Ala Ala Ala Met Tyr Lys Glu Ala Arg Ala Val Asn 
1               5                   10                  


<210>  29
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  29

Gln Thr Ser Gln Ala Leu Gln Thr Val Ala Thr Ala Leu Asn Lys 
1               5                   10                  15  


<210>  30
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  30

Ser Glu Ile Ser Ala Asn Gly Cys Ser Thr Ile Ala Gln Ala 
1               5                   10                  


<210>  31
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  31

Ser Asn Phe Asn Thr Leu Phe Ala Thr Thr Ile Pro Asn 
1               5                   10              


<210>  32
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  32

Thr Ile Gln Gly Pro Pro Gly Ser Gly Lys Ser 
1               5                   10      


<210>  33
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  33

Thr Asn Val Pro Leu Gln Val Gly Phe Ser Asn Gly 
1               5                   10          


<210>  34
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  34

Thr Asn Val Pro Leu Gln Val Gly Phe Ser Asn Gly 
1               5                   10          


<210>  35
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  35

Val Leu Phe Ser Ala Thr Ala Val Lys Thr Gly Gly Lys 
1               5                   10              


<210>  36
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  36

Val Leu Asn Asn Gly Phe Gly Gly Lys Gln Ile 
1               5                   10      


<210>  37
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MHC class I peptide

<400>  37

Val Thr Ser Gly Leu Gly Thr Val Asp Ala Asp Tyr 
1               5                   10          


<210>  38
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide portion of linker

<400>  38

Phe Leu Ala Ala Tyr 
1               5   


<210>  39
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide portion of linker

<400>  39

Leu Ala Ala Tyr 
1               


